Contact Dermatitis Clinical Trial
Official title:
Children With Aluminium Contact Allergy: Oral Exposure Study (the Pancake Study)
NCT number | NCT04921163 |
Other study ID # | H-20060917 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | June 1, 2021 |
Est. completion date | June 15, 2022 |
Verified date | March 2023 |
Source | National Allergy Research Center, Denmark |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Aluminium allergy is predominantly seen in children with small itchy nodules in the skin after vaccinations, so-called granulomas. We want to do an exposure study where aluminium allergic children have to eat aluminium pancakes for a short period of time. The purpose is to investigate whether a worsening of the children's symptoms can be detected, both itching of the granuloma, allergic rash on the skin and also the symptoms that are not measurable, such as headache, stomach ache and general agitation. We also want to examine the concentration of aluminium in the urine, which reflects the absorption of aluminum from the gastrointestinal tract.
Status | Completed |
Enrollment | 15 |
Est. completion date | June 15, 2022 |
Est. primary completion date | May 15, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 1 Year to 12 Years |
Eligibility | Inclusion Criteria: - Children with contact allergies to aluminium, demonstrated by patch tests - Activity (itching) of the granulom within the last six months - Written consent obtained from all custodians Exclusion Criteria: - a detected food allergy for the remaining products in the pancakes (including wheat flour, eggs and milk) - Children treated with topical and/or systemic steroid preparations during and up to 1 week before the start of the study. - Children treated with systemic immune suppression during and up to 1 week before the start of the study. - Children with kidney or bone disease. - Children vaccinated during the study period - Treatment with acid neutralising medicines during and up to 1 week before the start of the study - Another reason for inability to cooperate, including lack of language skills in Danish or English in parents. |
Country | Name | City | State |
---|---|---|---|
Denmark | National Allergy Research Centre | Hellerup |
Lead Sponsor | Collaborator |
---|---|
National Allergy Research Center, Denmark |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | granuloma | itch of existing granuloma evaluated on a Visual analogue scale 0-10 | 1-7 days | |
Primary | skin | flare-up of previous patch test area, evaluated on a visual scheme | 1-7 days | |
Primary | subjective | headache, irritability, stomach ache evaluated on an adapted visual analogue scale 0-10 | 1-7 days | |
Secondary | sleep | disturbed sleep evaluated by an activity tracker watch during sleep. The watch records all movements during sleep, and we especially focus on the number of times the child wakes up at night | 1-7 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00371163 -
Molecular and Cellular Characterization of Spongiotic Dermatitis
|
N/A | |
Completed |
NCT02028208 -
Clinical Evaluation of Metal Panel Allergens: Mercury, Aluminum and Palladium Dose Response Study
|
Phase 2 | |
Not yet recruiting |
NCT04853823 -
A Safety, Tolerability, and Dermal Reactogenicity Study of PDC-APB
|
Phase 1 | |
Recruiting |
NCT06387472 -
DermAI to Evaluate Human Factor of Testing
|
N/A | |
Completed |
NCT02700373 -
A Phase I, Single-Center Study of PDC-APB in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT03089775 -
Evaluation of Safety and Efficacy of BBI-2000 in Treating and Preventing Contact Dermatitis
|
Phase 1 | |
Completed |
NCT04438135 -
Children With Aluminium Contact Allergy: Cutaneous Exposure Study
|
N/A | |
Recruiting |
NCT06189144 -
Testing an Intervention in Irritative Contact Dermatitis
|
N/A | |
Not yet recruiting |
NCT02026700 -
Bariederm Cream in Chronic Contact Dermatitis
|
N/A | |
Completed |
NCT02028182 -
Clinical Evaluation of Lyral® Dose Response Study
|
Phase 2 | |
Completed |
NCT00824889 -
Exploratory Study of Natural Killer Cells in Human Skin
|
N/A | |
Completed |
NCT00646867 -
Effect of Tetrix on Alleviation of Burning,Itching Associated With Lesions of Contact Dermatitis
|
N/A | |
Withdrawn |
NCT01518348 -
Clinical Evaluation of T.R.U.E. TEST Panel 3.2 in Children and Adolescents
|
Phase 3 | |
Recruiting |
NCT03705182 -
Prevention of Dermatitis in Epoxy Exposed Workers
|
N/A | |
Terminated |
NCT03198390 -
Linking Epidermal Barrier Function With Anti-Oxidant Defense Mechanisms in Skin Conditions
|
||
Completed |
NCT00614289 -
Novel Topical Treatment of Hand Dermatitis (Eczema)
|
Phase 1 | |
Recruiting |
NCT06331390 -
Assessment of Niacinamide Cosmetic Product Efficacy in Model of Irritant Contact Dermatitis
|
N/A | |
Completed |
NCT00640614 -
Clinical Evaluation of T.R.U.E. TEST® : Safety and Efficacy
|
Phase 3 | |
Completed |
NCT00640250 -
Clinical Evaluation of T.R.U.E. TEST® Panel 3.2 Allergens: Dose Response
|
Phase 2 | |
Recruiting |
NCT06177314 -
Molecular Diagnosis of Allergic Contact Dermatitis
|